Submitted by: Submitted by vasu123
Views: 10
Words: 814
Pages: 4
Category: Business and Industry
Date Submitted: 03/16/2016 11:04 PM
BioCheck, Inc. - Product Pipeline Analysis, 2016 Update – Size, Share,
Analysis, Forecast, Trends And Growth Report
Summary
BioCheck, Inc. (BioCheck), a subsidiary of OriGene Technologies, Inc. is a medical device
company that develops, manufactures, and distributes enzyme immunoassay test kits and
research reagents for the healthcare and research markets. The company's products include
antibodies, conjugates, enzyme immunoassay kits, research reagents, rabbit monoclonal
antibodies, positive human serum antibodies, torch antigens, diluents, cardiac and tumor
markers, steroids, ID protein reagents, and other reagents, among others. It offers services such
as custom immunoassay development, antibody purification and conjugation, and contract
manufacturing and assembly services. BioCheck offers its products and services to biomedical,
pharmaceutical, and scientific research markets. The company distributes its products to
countries in Central and South America, Europe, the Middle East, and Asia. BioCheck is
headquartered in Foster, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio
of pipeline products. The report provides key information about the company, its major products
and brands.
To Get More Details @ http://www.radiantinsights.com/research/biocheck-inc-productpipeline-analysis-2016-update
The report enhances decision making capabilities and help to create effective counter strategies
to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key
company facts, major products and services, key competitors, key employees, locations and
subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioCheck, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment
type, by indication, by development stage, and by trial status)
- The report...